➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Express Scripts
AstraZeneca
Merck
Harvard Business School

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

PROSTASCINT Drug Profile


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for PROSTASCINT

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Molecular Insight Pharmaceuticals, Inc.Phase 1
National Cancer Institute (NCI)Phase 2
David M. Schuster, MDPhase 2

See all PROSTASCINT clinical trials

Recent Litigation for PROSTASCINT

Identify key patents and potential future biosimilar entrants

PTAB Litigation
PetitionerDate
2017-12-20

See all PROSTASCINT litigation

Patent Text Search: US Patents for PROSTASCINT

These patents were identified by searching patent claims

Supplementary Protection Certificates for PROSTASCINT

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
300822 Netherlands   Try Before You Buy PRODUCT NAME: RITUXIMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/98/067/003 - UITVOERINGSBESLUIT C(2014)2048 20140326
122015000061 Germany   Try Before You Buy PRODUCT NAME: TRASTUZUMAB UND RECOMBINANTE HUMANE HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
132016000070123 Italy   Try Before You Buy PRODUCT NAME: RITUXIMAB IN ASSOCIAZIONE CON IALURONIDASI RICOMBINANTE UMANA - SOLUZIONE PER INIEZIONE SOTTOCUTANEA(MABTHERA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/98/067/001-003, 20140326
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Colorcon
McKesson
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.